1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SIGA TECHNOLOGIES INC
SIGA Technologies Inc
XNAS: SIGA
Weak Stock
Download real time
3.17 -0.02 (-0.63%)
62.88% Fall from 52W High
908.9K
XNAS Volume

XNAS 16 Oct, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for SIGA Tech Inc

The latest disclosure was made by General John M. Keane, (Ret.) in SIGA Tech Inc where a trade of 34,169 Restricted Stock Units done was reported to US exchanges on June 9, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
General John M. Keane, (Ret.) Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
General John M. Keane, (Ret.) Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 24,116 (0%) 0% - Common Stock, par value $.0001 per share
General John M. Keane, (Ret.) Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 16,881 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
General John M. Keane, (Ret.) Director 09 Jun 2026 24,116 0 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 95,989 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director 09 Jun 2026 24,116 0 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 88,754 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 253,758 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 246,523 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director 09 Jun 2026 24,116 0 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 54,773 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Harold E. Ford, Jr Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director 09 Jun 2026 24,116 0 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 47,538 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 80,989 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
Mr. Julian Nemirovsky Director 09 Jun 2026 24,116 0 - - Restricted Stock Units
Mr. Julian Nemirovsky Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 73,754 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 73,754 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D.,PhD Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 80,989 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 09 Jun 2026 24,116 0 - - Restricted Stock Unites
Dr. Holly L. Phillips, M.D. Director Sale or transfer of securities back to the company at price $ 4.39 per share. 09 Jun 2026 7,235 73,754 (0%) 0% 4.4 31,762 Common Stock, par value $.0001 per share
Dr. Holly L. Phillips, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2026 24,116 80,989 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Holly L. Phillips, M.D. Director 09 Jun 2026 24,116 0 - - Restricted Stock Units
Dr. Holly L. Phillips, M.D. Director 09 Jun 2026 34,169 34,169 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Mar 2026 6,920 55,438 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.99 per share. 25 Mar 2026 3,526 51,912 (0%) 0% 5.0 17,595 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel 25 Mar 2026 6,920 6,921 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. 13 Mar 2026 3,955 198,537 (0%) 0% 5.3 20,803 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer 13 Mar 2026 11,445 22,891 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer 13 Mar 2026 54,942 54,942 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2026 11,445 202,492 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO 13 Mar 2026 55,228 55,228 - - Restricted Stock Units
Mr. Daniel J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. 13 Mar 2026 6,074 280,493 (0%) 0% 5.3 31,949 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2026 11,503 286,567 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO 13 Mar 2026 11,503 23,008 - - Restricted Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 13 Mar 2026 85,045 170,092 - - Restricted Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2026 85,045 185,796 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. 13 Mar 2026 47,029 138,767 (0%) 0% 5.3 247,373 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 13 Mar 2026 272,243 272,243 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. 13 Mar 2026 11,187 48,518 (0%) 0% 5.3 58,844 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel 13 Mar 2026 21,261 42,523 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel 13 Mar 2026 68,060 68,060 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2026 21,261 59,705 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2026 11,445 202,492 (0%) 0% 0 -
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. 13 Mar 2026 3,955 198,537 (0%) 0% 5.3 20,803 -
Mr. Daniel Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2026 11,503 286,567 (0%) 0% 0 -
Mr. Daniel Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. 13 Mar 2026 6,074 280,493 (0%) 0% 5.3 31,949 -
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2026 55,902 123,555 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.82 per share. 27 Jan 2026 22,804 100,751 (0%) 0% 6.8 155,523 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 27 Jan 2026 55,902 55,903 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2025 32,258 201,514 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer 01 Jul 2025 32,258 0 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.49 per share. 01 Jul 2025 10,467 191,047 (0%) 0% 6.5 67,931 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2025 24,193 287,410 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO 01 Jul 2025 24,193 0 - - Restricted Stock Units
Mr. Daniel J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.49 per share. 01 Jul 2025 12,346 275,064 (0%) 0% 6.5 80,126 Common Stock, par value $.0001 per share
General John M. Keane, (Ret.) Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 19,084 77,598 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director 10 Jun 2025 19,084 0 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Sale or transfer of securities back to the company at price $ 6.22 per share. 10 Jun 2025 5,725 71,873 (0%) 0% 6.2 35,610 Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 10 Jun 2025 19,084 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Sale or transfer of securities back to the company at price $ 6.22 per share. 10 Jun 2025 5,725 229,642 (0%) 0% 6.2 35,610 Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 19,084 235,367 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Harold E. Ford, Jr Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 19,084 36,382 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Harold E. Ford, Jr Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director 10 Jun 2025 19,084 0 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director Sale or transfer of securities back to the company at price $ 6.22 per share. 10 Jun 2025 5,725 30,657 (0%) 0% 6.2 35,610 Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Mr. Julian Nemirovsky Director 10 Jun 2025 19,084 0 - - Restricted Stock Units
Mr. Julian Nemirovsky Director Sale or transfer of securities back to the company at price $ 6.22 per share. 10 Jun 2025 5,725 56,873 (0%) 0% 6.2 35,610 Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 19,084 62,598 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 19,084 62,598 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director Sale or transfer of securities back to the company at price $ 6.22 per share. 10 Jun 2025 5,725 56,873 (0%) 0% 6.2 35,610 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 10 Jun 2025 19,084 0 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D.,PhD Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Dr. Holly L. Phillips, M.D. Director 10 Jun 2025 19,084 0 - - Restricted Stock Units
Dr. Holly L. Phillips, M.D. Director Sale or transfer of securities back to the company at price $ 6.22 per share. 10 Jun 2025 5,725 56,873 (0%) 0% 6.2 35,610 Common Stock, par value $.0001 per share
Dr. Holly L. Phillips, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 19,084 62,598 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Holly L. Phillips, M.D. Director 10 Jun 2025 24,116 24,116 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Apr 2025 6,920 41,976 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel 18 Apr 2025 13,841 13,841 - - Performance Stock Units
Mr. Larry R. Miller General Counsel 18 Apr 2025 13,841 0 - - Performance Stock Units
Mr. Larry R. Miller General Counsel 18 Apr 2025 6,920 13,841 - - Performance Stock Units
Mr. Larry R. Miller General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.99 per share. 18 Apr 2025 3,532 38,444 (0%) 0% 6.0 21,157 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel 25 Mar 2025 6,920 13,841 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.89 per share. 25 Mar 2025 2,764 35,056 (0%) 0% 5.9 16,280 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Mar 2025 6,920 37,820 (0%) 0% 0 Common Stock, par value $.0001 per share
General John M. Keane, (Ret.) Director 17 Mar 2025 25,000 25,000 - - Stock Option (Right to buy)
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer 13 Mar 2025 34,336 34,336 - - Restricted Stock Units
Mr. Daniel J. Luckshire Executive VP & CFO 13 Mar 2025 34,511 34,511 - - Restricted Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 13 Mar 2025 255,137 255,137 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel 13 Mar 2025 63,784 63,784 - - Restricted Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 55,902 91,297 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. 27 Jan 2025 23,644 67,653 (0%) 0% 6.3 149,903 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 27 Jan 2025 55,902 111,805 - - Restricted Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 25 Oct 2024 59,288 118,577 - - Performance Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.77 per share. 25 Oct 2024 23,893 35,395 (0%) 0% 6.8 161,756 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2024 59,288 59,288 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer 01 Jul 2024 32,258 32,258 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.55 per share. 01 Jul 2024 10,467 169,256 (0%) 0% 7.6 79,026 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2024 32,258 179,723 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2024 24,194 275,564 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel J. Luckshire Executive VP & CFO 01 Jul 2024 24,194 24,193 - - Restricted Stock Units
Mr. Daniel J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.55 per share. 01 Jul 2024 12,347 263,217 (0%) 0% 7.6 93,220 Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 65,928 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 58,514 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 223,697 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 216,283 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Mr. Harold E. Ford, Jr Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Mr. Harold E. Ford, Jr Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 17,298 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Mr. Harold E. Ford, Jr Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 24,712 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 43,514 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Mr. Julian Nemirovsky Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Mr. Julian Nemirovsky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 50,928 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D.,PhD Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 50,928 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 43,514 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Dr. Holly L. Phillips, M.D. Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 43,514 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Dr. Holly L. Phillips, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 50,928 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Holly L. Phillips, M.D. Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Dr. Holly L. Phillips, M.D. Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Dr. Jay K. Varma Director, EVP & Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 24,712 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Jay K. Varma Director, EVP & Chief Medical Officer 11 Jun 2024 24,712 0 - - Restricted Stock Units
Dr. Jay K. Varma Director, EVP & Chief Medical Officer Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 17,298 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Mr. Evan A. Knisely Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Jun 2024 24,712 24,712 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Evan A. Knisely Director 11 Jun 2024 19,084 19,084 - - Restricted Stock Units
Mr. Evan A. Knisely Director 11 Jun 2024 24,712 0 - - Restricted Stock Units
Mr. Evan A. Knisely Director Sale or transfer of securities back to the company at price $ 7.86 per share. 11 Jun 2024 7,414 17,298 (0%) 0% 7.9 58,274 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel 25 Mar 2024 20,761 20,761 - - Performance Stock Units
Mr. Larry R. Miller General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.35 per share. 25 Mar 2024 19,040 30,900 (0%) 0% 8.4 158,984 Common Stock, par value $.0001 per share
Mr. Larry R. Miller General Counsel 25 Mar 2024 61,347 61,347 - - Stock Option (Right to buy)
Mr. Larry R. Miller General Counsel 25 Mar 2024 25,504 25,504 - - Stock Option (Right to buy)
Mr. Larry R. Miller General Counsel 25 Mar 2024 20,761 20,761 - - Restricted Stock Units
Mr. Larry R. Miller General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 49,940 49,940 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 27 Jan 2024 219,212 219,212 - - Stock Option (Right to buy)
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 27 Jan 2024 167,707 167,707 - - Restricted Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 27 Jan 2024 177,865 177,865 - - Performance Stock Units
Dr. Diem Nguyen, M.B.A.,PhD Director, Chief Executive Officer 27 Jan 2024 109,606 109,606 - - Stock Option (Right to buy)
Mr. Jaymie A. Durnan Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2023 14,620 45,602 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director Sale or transfer of securities back to the company at price $ 6.07 per share. 13 Jun 2023 4,386 41,216 (0%) 0% 6.1 26,623 Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director 13 Jun 2023 14,620 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 13 Jun 2023 14,620 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2023 14,620 203,371 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director Sale or transfer of securities back to the company at price $ 6.07 per share. 13 Jun 2023 4,386 198,985 (0%) 0% 6.1 26,623 Common Stock, par value $.0001 per share
Mr. Harold Ford, Jr Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Julian Nemirovsky Director Sale or transfer of securities back to the company at price $ 6.07 per share. 13 Jun 2023 4,386 26,216 (0%) 0% 6.1 26,623 Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Julian Nemirovsky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2023 14,620 30,602 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director 13 Jun 2023 14,620 0 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D.,PhD Director Sale or transfer of securities back to the company at price $ 6.07 per share. 13 Jun 2023 4,386 26,216 (0%) 0% 6.1 26,623 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D.,PhD Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2023 14,620 30,602 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 13 Jun 2023 14,620 0 - - Restricted Stock Units
Dr. Holly Phillips, M.D. Director 13 Jun 2023 14,620 0 - - Restricted Stock Units
Dr. Holly Phillips, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jun 2023 14,620 30,602 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Holly Phillips, M.D. Director Sale or transfer of securities back to the company at price $ 6.07 per share. 13 Jun 2023 4,386 26,216 (0%) 0% 6.1 26,623 Common Stock, par value $.0001 per share
Dr. Holly Phillips, M.D. Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Jay Varma Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Evan Knisely Director 13 Jun 2023 24,712 24,712 - - Restricted Stock Units
Mr. Evan Knisely Director 13 Jun 2023 25,000 25,000 - - Stock Option (Right to buy)
Dr. Dennis E. Hruby,PhD EVP & Chief Scientific Officer 11 May 2023 64,516 64,516 - - Restricted Stock Units
Mr. Daniel Luckshire Executive VP & CFO 11 May 2023 48,387 48,387 - - Restricted Stock Units
Mr. Harold Ford Director 10 Nov 2022 25,000 25,000 - - Stock Option (Right to buy)
Mr. Jay Varma Director 10 Nov 2022 25,000 25,000 - - Stock Option (Right to buy)
Mr. James J. Antal Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Mr. James J. Antal Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Mr. James J. Antal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 123,706 (0%) 0% - Common Stock, par value $.0001 per share
Mr. James J. Antal Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 116,857 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 30,982 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 37,831 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 195,600 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 188,751 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Mr. Michael C. Plansky Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Mr. Michael C. Plansky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 82,831 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Michael C. Plansky Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Mr. Michael C. Plansky Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 75,982 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Ms. Julie M. Kane Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Ms. Julie M. Kane Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Ms. Julie M. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 55,331 (0%) 0% - Common Stock, par value $.0001 per share
Ms. Julie M. Kane Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 48,482 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Mr. Julian Nemirovsky Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Mr. Julian Nemirovsky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 22,831 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Julian Nemirovsky Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 15,982 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 15,982 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 22,831 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Gary J. Nabel, M.D.,PhD Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D.,PhD Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Dr. Holly Phillips, M.D. Director 14 Jun 2022 22,831 0 - - Restricted Stock Units
Dr. Holly Phillips, M.D. Director 14 Jun 2022 14,620 14,620 - - Restricted Stock Units
Dr. Holly Phillips, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2022 22,831 22,831 (0%) 0% - Common Stock, par value $.0001 per share
Dr. Holly Phillips, M.D. Director Sale or transfer of securities back to the company at price $ 10.26 per share. 14 Jun 2022 6,849 15,982 (0%) 0% 10.3 70,271 Common Stock, par value $.0001 per share
Mr. Daniel Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.37 per share. 31 Jul 2021 13,902 251,370 (0%) 0% 6.4 88,556 Common Stock, Par Value $.0001 Per Share
Mr. Daniel Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2021 26,667 265,272 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Daniel Luckshire Executive VP & CFO 31 Jul 2021 26,667 0 - - Restricted Stock Units
Ms. Robin E. Abrams General Counsel and CAO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2021 26,667 61,088 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Ms. Robin E. Abrams General Counsel and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.37 per share. 31 Jul 2021 11,301 49,787 (0%) 0% 6.4 71,987 Common Stock, Par Value $.0001 Per Share
Ms. Robin E. Abrams General Counsel and CAO 31 Jul 2021 26,667 0 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 1,068,593 (1%) 0% - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Mr. James J. Antal Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Mr. James J. Antal Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Mr. James J. Antal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 130,875 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 15,000 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Jaymie A. Durnan Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Mr. Thomas E. Constance Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 327,806 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Thomas E. Constance Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 172,769 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Joseph W. Marshall, III Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Mr. Michael C. Plansky Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Mr. Michael C. Plansky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 60,000 (0%) 0% - Common Stock, par value $.0001 per share
Mr. Michael C. Plansky Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Ms. Julie M. Kane Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Ms. Julie M. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 15,000 32,500 (0%) 0% - Common Stock, par value $.0001 per share
Ms. Julie M. Kane Director 15 Jun 2021 15,000 0 - - Restricted Stock Units
Mr. Julian Nemirovsky Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D. Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Dr. Gary J. Nabel, M.D. Director 15 Jun 2021 25,000 25,000 - - Stock Option (Right to buy)
Dr. Holly Phillips, M.D. Director 15 Jun 2021 22,831 22,831 - - Restricted Stock Units
Dr. Holly Phillips, M.D. Director 15 Jun 2021 25,000 25,000 - - Stock Option (Right to buy)
Mr. Julian Nemirovsky Director 10 Dec 2020 25,000 25,000 - - Stock Option (Right to buy)
Mr. James J. Antal Director Sale of securities on an exchange or to another person at price $ 7.10 per share. 27 Aug 2020 30,000 115,875 (0%) 0% 7.1 213,000 Common Stock, Par Value $.0001 Per Share
Mr. Edward P. Taibi Director 06 Aug 2020 25,000 25,000 - - Stock Option (Right to buy)
Mr. Edward P. Taibi Director 06 Aug 2020 15,000 15,000 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.42 per share. 31 Jul 2020 13,005 238,605 (0%) 0% 6.4 83,492 Common Stock, Par Value $.0001 Per Share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 31 Jul 2020 26,667 26,667 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 26,667 251,610 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Ms. Robin E. Abrams General Counsel and CAO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2020 26,667 48,559 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Ms. Robin E. Abrams General Counsel and CAO 31 Jul 2020 26,667 26,667 - - Restricted Stock Units
Ms. Robin E. Abrams General Counsel and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.42 per share. 31 Jul 2020 14,138 34,421 (0%) 0% 6.4 90,766 Common Stock, Par Value $.0001 Per Share
Dr. Eric A. Rose, M.D. Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Mr. James J. Antal Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Mr. Paul G. Savas Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Mr. Jaymie A. Durnan Director 16 Jun 2020 25,000 25,000 - - Stock Option (Right to buy)
Mr. Jaymie A. Durnan Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Mr. Thomas E. Constance Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Mr. Michael C. Plansky Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Ms. Julie M. Kane Director 16 Jun 2020 15,000 15,000 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 1,053,593 (1%) 0% 0 Common Stock, Par Value $.0001 Per Share
Dr. Eric A. Rose, M.D. Director 21 May 2020 15,000 0 - - Restricted Stock Units
Mr. James J. Antal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 145,875 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal Director 21 May 2020 15,000 0 - - Restricted Stock Units
Mr. Jeffrey B. Kindler Director 21 May 2020 15,000 0 - - Restricted Stock Units
Mr. Jeffrey B. Kindler Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 127,339 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas Director 21 May 2020 15,000 0 - - Restricted Stock Units
Mr. Paul G. Savas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 307,847 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 312,806 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance Director 21 May 2020 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 157,769 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Joseph W. Marshall, III Director 21 May 2020 15,000 0 - - Restricted Stock Units
Mr. Michael C. Plansky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 45,000 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Michael C. Plansky Director 21 May 2020 15,000 0 - - Restricted Stock Units
Ms. Julie M. Kane Director 21 May 2020 15,000 0 - - Restricted Stock Units
Ms. Julie M. Kane Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2020 15,000 17,500 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas Director Purchase of securities on an exchange or from another person at price $ 4.37 per share. 09 Dec 2019 20,000 292,847 (0%) 0% 4.4 87,400 Common Stock, Par Value $.0001 Per Share
Mr. Daniel Luckshire Executive VP & CFO Purchase of securities on an exchange or from another person at price $ 4.39 per share. 09 Dec 2019 5,000 224,943 (0%) 0% 4.4 21,950 Common Stock, Par Value $.0001 Per Share
Ms. Julie M. Kane Director Purchase of securities on an exchange or from another person at price $ 4.39 per share. 09 Dec 2019 2,500 2,500 (0%) 0% 4.4 10,975 Common Stock, Par Value $.0001 Per Share
Mr. Phillip Louis Gomez Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 4.42 per share. 09 Dec 2019 10,000 475,782 (0%) 0% 4.4 44,200 Common Stock, Par Value $.0001 Per Share
Dr. Eric A. Rose, M.D. Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.92 per share. 22 Nov 2019 54,501 1,038,593 (1%) 0% 4.9 268,145 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2019 100,000 1,093,094 (1%) 0% 0 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director 22 Nov 2019 100,000 0 - - Restricted Stock Units
Mr. Phillip Louis Gomez Director, Chief Executive Officer 22 Nov 2019 294,117 0 - - Restricted Stock Units
Mr. Phillip Louis Gomez Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.92 per share. 22 Nov 2019 144,028 465,782 (0%) 0% 4.9 708,618 Common Stock, par value $.0001 per share
Mr. Phillip Louis Gomez Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2019 294,117 609,810 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Paul G. Savas Director Purchase of securities on an exchange or from another person at price $ 4.95 per share. 23 Aug 2019 10,000 272,847 (0%) 0% 5.0 49,500 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas Director Purchase of securities on an exchange or from another person at price $ 5.08 per share. 09 Aug 2019 10,000 262,847 (0%) 0% 5.1 50,800 Common Stock, Par Value $.0001 Per Share
Ms. Robin E. Abrams General Counsel and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 26,666 34,680 (0%) 0% 0 Common Stock, par value $.0001 per share
Ms. Robin E. Abrams General Counsel and CAO 31 Jul 2019 53,334 53,334 - - Restricted Stock Units
Ms. Robin E. Abrams General Counsel and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. 31 Jul 2019 12,788 21,892 (0%) 0% 5.6 71,613 Common Stock, par value $.0001 per share
Mr. Daniel Luckshire Executive VP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 26,666 232,731 (0%) 0% 0 -
Mr. Daniel Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. 31 Jul 2019 12,788 219,943 (0%) 0% 5.6 71,613 -
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 5.68 per share. 05 Jun 2019 17,000 180,465 (0%) 0% 5.7 96,560 -
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 5.57 per share. 05 Jun 2019 17,000 163,645 (0%) 0% 5.6 94,690 -
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 5.58 per share. 05 Jun 2019 16,000 147,465 (0%) 0% 5.6 89,280 -
Mr. James J. Antal Director Sale of securities on an exchange or to another person at price $ 5.70 per share. 05 Jun 2019 30,000 130,875 (0%) 0% 5.7 171,000 -
Dr. Eric A. Rose, M.D. Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. James J. Antal Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. James J. Antal Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. James J. Antal Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 160,875 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Jeffrey B. Kindler, Esq. Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. Jeffrey B. Kindler, Esq. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 112,339 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Jeffrey B. Kindler, Esq. Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. Michael J. Bayer Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. Michael J. Bayer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 134,744 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Michael J. Bayer Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. Paul G. Savas Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. Paul G. Savas Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. Paul G. Savas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 252,847 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 297,806 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. Thomas E. Constance Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 142,769 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Joseph W. Marshall, III Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. Michael C. Plansky Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 May 2019 15,000 30,000 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Michael C. Plansky Director 21 May 2019 15,000 0 - - Restricted Stock Units
Mr. Michael C. Plansky Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Ms. Julie M. Kane Director 21 May 2019 25,000 25,000 - - Stock Option (Right to buy)
Ms. Julie M. Kane Director 21 May 2019 15,000 15,000 - - Restricted Stock Units
Mr. Joseph W. Marshall, III Director 09 Jan 2019 25,000 0 - - Stock Option (Right to buy)
Mr. Joseph W. Marshall, III Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.74 per share. 09 Jan 2019 25,000 143,000 (0%) 0% 4.7 118,500 Common Stock, Par Value $.0001 Per Share
Mr. Joseph W. Marshall, III Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.78 per share. 09 Jan 2019 15,231 127,769 (0%) 0% 7.8 118,497 Common Stock, Par Value $.0001 Per Share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. 12 Dec 2018 28,614 206,065 (0%) 0% 6.4 182,557 Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 12 Dec 2018 58,965 234,679 (0%) 0% 3.5 208,146 Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 12 Dec 2018 132,000 0 - - Stock-Settled Stock Appreciation Rights
Dr. Eric A. Rose, M.D. None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2018 200,000 1,098,990 (1%) 0% 0 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. None 22 Nov 2018 200,000 100,000 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. None Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.55 per share. 22 Nov 2018 105,896 993,094 (1%) 0% 5.6 587,723 Common Stock, par value $.0001 per share
Mr. Phillip Louis Gomez Director, Chief Executive Officer 22 Nov 2018 588,236 294,117 - - Restricted Stock Units
Mr. Phillip Louis Gomez Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.55 per share. 22 Nov 2018 287,543 315,693 (0%) 0% 5.6 1,595,864 Common Stock, par value $.0001 per share
Mr. Phillip Louis Gomez Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2018 588,236 603,236 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Paul G. Savas None Purchase of securities on an exchange or from another person at price $ 5.58 per share. 16 Nov 2018 5,000 237,847 (0%) 0% 5.6 27,900 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas None Purchase of securities on an exchange or from another person at price $ 5.01 per share. 12 Nov 2018 10,000 232,847 (0%) 0% 5.0 50,100 Common Stock, Par Value $.0001 Per Share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 4.96 per share. 12 Nov 2018 18,901 228,564 (0%) 0% 5.0 93,749 Common Stock, Par Value $.0001 Per Share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 5.29 per share. 12 Nov 2018 31,099 197,465 (0%) 0% 5.3 164,514 Common Stock, Par Value $.0001 Per Share
Mr. Phillip Louis Gomez Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.20 per share. 12 Nov 2018 15,000 15,000 (0%) 0% 5.2 78,000 Common Stock, Par Value $.0001 Per Share
Mr. Michael J. Bayer None Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.32 per share. 16 Oct 2018 14,756 119,744 (0%) 0% 5.3 78,502 Common Stock, par value $.0001 per share
Mr. Michael J. Bayer None 16 Oct 2018 25,000 0 - - Stock Option (Right to buy)
Mr. Michael J. Bayer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. 16 Oct 2018 25,000 134,500 (0%) 0% 3.1 78,500 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. 11 Sep 2018 50,000 267,461 (0%) 0% 4.7 235,000 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. 11 Sep 2018 12,175 247,465 (0%) 0% 7.2 87,173 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. 11 Sep 2018 32,821 234,640 (0%) 0% 7.2 234,998 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2018 25,000 259,640 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.16 per share. 11 Sep 2018 8,853 217,461 (0%) 0% 7.2 63,387 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 11 Sep 2018 18,174 226,314 (0%) 0% 3.5 64,154 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 11 Sep 2018 37,500 0 - - Stock-Settled Stock Appreciation Rights
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 11 Sep 2018 50,000 0 - - Stock Option (Right to buy)
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 11 Sep 2018 25,000 0 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.98 per share. 20 Aug 2018 234,277 898,990 (1%) 0% 8.0 1,869,530 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman 20 Aug 2018 400,000 0 - - Stock Option (Right to buy)
Dr. Eric A. Rose, M.D. Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. 20 Aug 2018 400,000 1,133,267 (1%) 0% 2.5 996,000 Common Stock, par value $.0001 per share
Ms. Robin E. Abrams General Counsel and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Aug 2018 15,000 15,000 (0%) 0% 0 Common Stock, par value $.0001 per share
Ms. Robin E. Abrams General Counsel and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.98 per share. 20 Aug 2018 6,986 8,014 (0%) 0% 8.0 55,748 Common Stock, par value $.0001 per share
Mr. James J. Antal None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. James J. Antal None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 145,875 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Jeffrey B. Kindler None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 97,339 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Jeffrey B. Kindler None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Jeffrey B. Kindler None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. Michael J. Bayer None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. Michael J. Bayer None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Michael J. Bayer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 109,500 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. Paul G. Savas None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Paul G. Savas None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 222,847 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 282,806 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. Thomas E. Constance None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Joseph W. Marshall, III None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 118,000 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Joseph W. Marshall, III None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Michael C. Plansky None 22 May 2018 15,000 15,000 - - Restricted Stock Units
Mr. Michael C. Plansky None 22 May 2018 15,000 0 - - Restricted Stock Units
Mr. Michael C. Plansky None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2018 15,000 15,000 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal None Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 18 Apr 2018 10,000 136,487 (0%) 0% 3.5 35,300 Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal None 18 Apr 2018 10,000 0 - - Stock Option (Right to Buy)
Mr. James J. Antal None Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.29 per share. 18 Apr 2018 5,612 130,875 (0%) 0% 6.3 35,299 Common Stock, par value $.0001 per share
Mr. Thomas E. Constance None Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 17 Apr 2018 10,000 273,500 (0%) 0% 3.5 35,300 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance None Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.20 per share. 17 Apr 2018 5,694 267,806 (0%) 0% 6.2 35,303 Common Stock, par value $.0001 per share
Mr. Thomas E. Constance None 17 Apr 2018 10,000 0 - - Stock Option (Right to Buy)
Mr. Paul G. Savas None Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 16 Apr 2018 10,000 213,504 (0%) 0% 3.5 35,300 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas None Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. 16 Apr 2018 5,657 207,847 (0%) 0% 6.2 35,300 Common Stock, par value $.0001 per share
Mr. Paul G. Savas None 16 Apr 2018 10,000 0 - - Stock Option (Right to Buy)
Dr. Eric A. Rose, M.D. Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.47 per share. 13 Nov 2017 49,446 733,267 (0%) 0% 4.5 221,024 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman 13 Nov 2017 465,000 0 - - Stock-Settled Stock Appreciation Rights
Dr. Eric A. Rose, M.D. Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 13 Nov 2017 97,785 782,713 (0%) 0% 3.5 345,181 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 10 Nov 2017 337,500 0 - - Stock-Settled Stock Appreciation Rights
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.60 per share. 10 Nov 2017 29,439 208,140 (0%) 0% 4.6 135,419 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.53 per share. 10 Nov 2017 71,168 237,579 (0%) 0% 3.5 251,223 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 08 Jun 2017 25,000 25,000 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 08 Jun 2017 200,000 100,000 - - Stock Option (Right to buy)
Mr. James J. Antal None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Jeffrey B. Kindler None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Michael J. Bayer None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Paul G. Savas None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Thomas E. Constance None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Joseph W. Marshall, III None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Michael C. Plansky None 23 May 2017 25,000 25,000 - - Stock Option (Right to buy)
Mr. Michael C. Plansky None 23 May 2017 15,000 15,000 - - Restricted Stock Units
Mr. Bruce Slovin None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. Bruce Slovin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 194,167 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. James J. Antal None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 126,487 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Jeffrey B. Kindler None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 82,339 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Jeffrey B. Kindler None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. Michael J. Bayer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 94,500 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Michael J. Bayer None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. Paul G. Savas None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 203,504 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Paul G. Savas None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. Thomas E. Constance None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 263,500 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Thomas E. Constance None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III None 17 May 2017 15,000 0 - - Restricted Stock Units
Mr. Joseph W. Marshall, III None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 103,000 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Andrew L. Stern None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2017 15,000 77,865 (0%) 0% 0 Common Stock, Par Value $.0001 Per Share
Mr. Andrew L. Stern None 17 May 2017 15,000 0 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 03 Jan 2017 29,502 684,928 (0%) 0% 2.9 86,441 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2017 66,667 714,430 (0%) 0% 0 Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman 03 Jan 2017 66,667 0 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 03 Jan 2017 25,000 0 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 03 Jan 2017 10,413 166,411 (0%) 0% 2.9 30,510 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2017 25,000 176,824 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2017 33,334 189,743 (0%) 0% 0 Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 03 Jan 2017 33,334 0 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 03 Jan 2017 14,029 175,714 (0%) 0% 2.9 41,105 Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2016 25,000 147,124 - - Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2016 25,000 172,124 - - Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 08 Dec 2016 25,000 25,000 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 08 Dec 2016 25,000 0 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Dec 2016 20,300 151,824 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2016 66,668 716,232 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman 08 Dec 2016 66,667 0 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Dec 2016 68,469 647,763 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2016 66,667 649,564 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman 08 Dec 2016 66,668 66,667 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 08 Dec 2016 33,335 0 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 08 Dec 2016 24,611 156,409 - - Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 08 Dec 2016 33,333 33,334 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2016 33,333 181,020 - - Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2016 33,335 147,687 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Executive Chairman 22 Nov 2016 300,000 300,000 - - Restricted Stock Units
Mr. Phillip Louis Gomez Chief Executive Officer 22 Nov 2016 882,353 882,353 - - Restricted Stock Units
Ronald O. Perelman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Nov 2016 565,010 24,156,358 - - Common Stock, Par Value $.0001 Per Share
Ronald O. Perelman Director, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 10,060,643 23,591,348 - - Common Stock, Par Value $.0001 Per Share
Michael J. Bayer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 19,500 79,500 - - Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 30,333 111,487 - - Common Stock, Par Value $.0001 Per Share
Thomas E. Constance None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 33,500 248,500 - - Common Stock, Par Value $.0001 Per Share
Jeffrey B. Kindler None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 22,339 67,339 - - Common Stock, Par Value $.0001 Per Share
Mr. Bruce Slovin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 54,167 179,167 - - Common Stock, Par Value $.0001 Per Share
Paul G. Savas None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 66,664 188,504 - - Common Stock, Par Value $.0001 Per Share
Joseph W. Marshall,III None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 13,000 88,000 - - Common Stock, Par Value $.0001 Per Share
Mr. Andrew L. Stern None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 715 62,865 - - Common Stock, Par Value $.0001 Per Share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2016 10,000 114,352 - - Common Stock, par value $.0001 per share
Michael J. Bayer None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Michael J. Bayer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 60,000 - - Common Stock, Par Value $.0001 Per Share
Michael J. Bayer None 14 May 2016 15,000 0 - - Restricted Stock Units
Mr. James J. Antal None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 81,154 - - Common Stock, Par Value $.0001 Per Share
Mr. James J. Antal None 14 May 2016 15,000 0 - - Restricted Stock Units
Mr. James J. Antal None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Thomas E. Constance None 14 May 2016 15,000 0 - - Restricted Stock Units
Thomas E. Constance None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 215,000 - - Common Stock, Par Value $.0001 Per Share
Thomas E. Constance None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Jeffrey B. Kindler None 14 May 2016 15,000 0 - - Restricted Stock Units
Jeffrey B. Kindler None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Jeffrey B. Kindler None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 45,000 - - Common Stock, Par Value $.0001 Per Share
Mr. Bruce Slovin None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Mr. Bruce Slovin None 14 May 2016 15,000 0 - - Restricted Stock Units
Mr. Bruce Slovin None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 125,000 - - Common Stock, Par Value $.0001 Per Share
Paul G. Savas None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 121,840 - - Common Stock, Par Value $.0001 Per Share
Paul G. Savas None 14 May 2016 15,000 0 - - Restricted Stock Units
Paul G. Savas None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Joseph W. Marshall,III None 14 May 2016 15,000 0 - - Restricted Stock Units
Joseph W. Marshall,III None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 75,000 - - Common Stock, Par Value $.0001 Per Share
Joseph W. Marshall,III None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Mr. Andrew L. Stern None 14 May 2016 15,000 0 - - Restricted Stock Units
Mr. Andrew L. Stern None 14 May 2016 15,000 15,000 - - Restricted Stock Units
Mr. Andrew L. Stern None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2016 15,000 62,150 - - Common Stock, Par Value $.0001 Per Share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Sep 2015 6,250 115,874 - - Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 23 Sep 2015 6,250 25,000 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Sep 2015 6,250 109,624 - - Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Sep 2015 6,250 122,124 - - Common Stock, par value $.0001 per share
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 23 Sep 2015 6,250 50,000 - - Restricted Stock Units
Dr. Dennis E. Hruby,PhD VP & Chief Scientific Officer 23 Sep 2015 6,250 0 - - Restricted Stock Units
Mr. William J. Haynes , II Executive VP & General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Sep 2015 6,250 57,687 - - Common Stock, par value $.0001 per share
Mr. William J. Haynes , II Executive VP & General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Sep 2015 6,250 63,937 - - Common Stock, par value $.0001 per share
Mr. William J. Haynes , II Executive VP & General Counsel 23 Sep 2015 6,250 25,000 - - Restricted Stock Units
Mr. William J. Haynes , II Executive VP & General Counsel 23 Sep 2015 6,250 50,000 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer 22 Sep 2015 16,666 66,667 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer 22 Sep 2015 16,667 0 - - Restricted Stock Units
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2015 16,667 602,897 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2015 16,666 586,230 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2015 16,667 569,564 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Sep 2015 20,000 582,897 - - Common Stock, par value $.0001 per share
Dr. Eric A. Rose, M.D. Director, Chief Executive Officer 22 Sep 2015 16,667 133,335 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 22 Sep 2015 8,333 33,335 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 22 Sep 2015 8,334 66,667 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO 22 Sep 2015 2,917 0 - - Restricted Stock Units
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2015 2,917 87,685 - - Common Stock, par value $.0001 per share
Mr. Daniel (Dan) J. Luckshire Executive VP & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Sep 2015 8,334 104,352 - - Common Stock, par value $.0001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters